These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3230336)

  • 21. [The value of tumor markers CA 15-3 and CEA in breast cancer].
    Buck I; Lindner C; Böge K; Kitschke HJ
    Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum markers for breast cancer.
    Stenman UH; Heikkinen R
    Scand J Clin Lab Invest Suppl; 1991; 206():52-9. PubMed ID: 1947760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CEA and CA 15-3 in primary and recurrent breast cancer.
    O'Dwyer PJ; Duffy MJ; O'Sullivan F; McDermott E; Losty P; O'Higgins NJ
    World J Surg; 1990; 14(5):562-5; discussion 565-6. PubMed ID: 2238654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers in breast cancer: does CEA add to the detection by CA 15.3?
    Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
    Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
    Bieglmayer C; Szepesi T; Neunteufel W
    Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
    Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
    Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
    Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
    Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of carcinoembryonic antigen, gastrointestinal cancer-associated antigen and alphafetoprotein in staging and management of patients with advanced carcinoma of the stomach.
    Szymendera JJ; Szawlowski AW; Nowacki MP; Kowalska M; Kaminska JA; Kozlowicz-Gudzinska I
    Int J Biol Markers; 1987; 2(1):19-24. PubMed ID: 2448400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma.
    Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M
    Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.
    Uehara M; Kinoshita T; Hojo T; Akashi-Tanaka S; Iwamoto E; Fukutomi T
    Int J Clin Oncol; 2008 Oct; 13(5):447-51. PubMed ID: 18946756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers in breast cancer: on the diagnostic value of serum determinations in clinical freedom from tumor and manifest disease].
    Günczler P; Ogris E; Maca S; Danmayr E
    Onkologie; 1989 Oct; 12(5):209-14. PubMed ID: 2685686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
    Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
    Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer.
    Kandylis K; Vassilomanolakis M; Baziotis N; Papadimitriou A; Tsoussis S; Ferderigou A; Efremidis AP
    Ann Oncol; 1990 Nov; 1(6):435-8. PubMed ID: 2083187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.
    Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
    Ann Oncol; 2013 May; 24(5):1225-31. PubMed ID: 23230137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse.
    Sugano K; Ushiama M; Fukutomi T; Tsuda H; Kitoh T; Ohkura H
    Int J Cancer; 2000 Jul; 89(4):329-36. PubMed ID: 10956406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.